About iwDS

logologo

About the Meeting

iwDS is a workshop led by scientific leaders in acute leukemias, which will bring together top clinical and translational research minds to discuss the latest advances in differentiation syndrome. 

In collaboration with relevant stakeholders, the aim is to identify key clinical and translational research priorities to help improve understanding and management of differentiation syndrome. 

In keeping with the ethos of iw meetings, the emphasis of the workshop will be on short, high-level presentations, complemented by sessions of interactive debate and panel discussions.

2025 Meeting

06-07 Nov

New York, NY, USA

Workshop Objectives

  • To establish an annual forum for scientific exchange of ideas, knowledge and research on DS, fostering discussion on its pathophysiology, diagnosis, and management of DS 
  • To promote global networking and foster interdisciplinary collaborations between clinicians, researchers, and industry experts focused on DS  
  • To create a unified platform for the scientific research community to provide focused input into the research priorities and future clinical trial designs, and guide improvements in patient care related to DS
about
circle strips

Meeting Organizer

Meeting Organizer

Magdalen Medical Publishing (MMP) is an agile and fast-growing digital publisher of independent, open-access medical news and education for the online healthcare professional community via their online video journals. 

In addition to online publishing, MMP also develops and organizes high-level scientific meetings and workshops that promote scientific exchange such as this meeting, by bringing together leading international clinical and translational research minds. 

For more information please visit www.MedicalPublishing.co.uk 

Media Partner 

Media Partner 

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date independent medical education to improve the awareness of advances in the management of hematology and hematological cancers and share best practice within the hematology community. 

The goal of the journal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals worldwide, in a range of innovative digital media – including video and blog formats. 

VJHemOnc content is led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of hematology and hematological malignancies. All content is created and published under the guidance of this board of world-leading experts. 

For more information, please visit www.VJHemOnc.com